Titel	Veröffentlichungsdatum	Sprache	Zitate
Vaso-occlusion in sickle cell anemia: role of interactions between blood cells and endothelium	2004/01/01		16
Second treatment with rituximab in B-cell non-Hodgkin's lymphoma: efficacy and toxicity on 41 patients treated at CHU-Lyon Sud	2004/01/01		16
An investigation of the effects of the MEK inhibitor U0126 on apoptosis in acute leukemia	2003/01/01		15
Bone marrow histopathology and biological markers as specific clues to the differential diagnosis of essential thrombocythemia, polycythemia vera and prefibrotic or fibrotic agnogenic myeloid metaplasia	2004/01/01		15
Retinoic acid dramatically enhances the arsenic trioxide-induced cell cycle arrest and apoptosis in retinoic acid receptor α-positive human T-cell lymphotropic virus type-I-transformed cells	2001/01/01		15
Treatment of CML using IFN-α: impact on quality of life	2003/01/01		15
Cytogenetic abnormalities in de novo acute myeloid leukemia in adults: relation to morphology, age, sex and ethnicity – a single center study from Singapore	2004/01/01		15
Graft-vs-leukemia activity and graft-vs-host disease induced by allogeneic Th1- and Th2-type CD4+ T cells in mice	2001/01/01		14
No correlation between the proliferative status of Bcr-Abl positive cell lines and the proapoptotic activity of imatinib mesylate (Gleevec™/Glivec®)	2003/01/01		14
Spectrum and haplotypes of the HFE hemochromatosis gene in Iran: H63D in β-thalassemia major and the first E277K homozygous	2004/01/01		14
Low-dose oral fludarabine plus cyclophosphamide in elderly patients with chronic lymphoproliferative disorders	2004/01/01		14
Use of fludarabine in the treatment of acute myeloid leukemia	2004/01/01		14
Liver iron concentration and fibrosis in a cohort of transfusion-dependent patients on long-term desferrioxamine therapy	2005/01/01		14
Expression and activation of SHC/MAP kinase pathway in primary acute myeloid leukemia blasts	2001/01/01		14
Severe gastrointestinal haemorrhage responding to recombinant factor VIIa in a Jehovah's Witness with refractory immune thrombocytopenia	2004/01/01		13
Role of fludarabine as monotherapy in the treatment of chronic lymphocytic leukemia	2004/01/01		13
Inherited aplastic anaemia	2003/01/01		13
High-dose daunorubicin as liposomal compound (Daunoxome®) in elderly patients with acute lymphoblastic leukemia1	2003/01/01		13
Normoblastosis, a murine model for ankyrin-deficient hemolytic anemia, is caused by a hypomorphic mutation in the erythroid ankyrin gene Ank1	2003/01/01		13
Resistance to CD95-mediated apoptosis of CD40-activated chronic lymphocytic leukemia B cells is not related to lack of DISC molecules expression	2004/01/01		13
Long-lasting remission of primary hepatic lymphoma and hepatitis C virus infection achieved by the alpha-interferon treatment	2004/01/01		13
HPA-genotyping and antiplatelet antibodies in female blood donors	2003/01/01		12
Bone remodelation markers are useful in the management of monoclonal gammopathies	2004/01/01		12
Feasibility and clinical significance of real-time quantitative RT–PCR assay of PML-RARα fusion transcript in patients with acute promyelocytic leukemia	2001/01/01		12
The specific enhancement of interferon alpha induced growth inhibition by BCR/ABL only occurs in multipotent cells	2001/01/01		12
Four-fold staining including CD45 gating improves the sensitivity of multiparameter flow cytometric assessment of minimal residual diseasein patients with acute myeloid leukemia	2004/01/01		12
Effective treatment of primary plasma cell leukemia with thalidomide and dexamethasone – a case report	2004/01/01		12
Comparison between conventional banding analysis and FISH screening with an AML-specific set of probes in 260 patients	2003/01/01		12
Exclusive TCRVβ chain usage of ex vivo generated minor Histocompatibility antigen HA-1 specific cytotoxic T cells: implications for monitoring of immunotherapy of leukemia by TCRBV spectratyping	2002/01/01		12
Acute tumor lysis syndrome in large B-cell non-Hodgkin lymphoma induced by steroids and anti-CD 20	2003/01/01		12